KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Medtronic (MDT) Net Margin (2016 - 2026)

Medtronic's Net Margin history spans 13 years, with the latest figure at 12.75% for Q1 2026.

  • For Q1 2026, Net Margin fell 296.0% year-over-year to 12.75%; the TTM value through Jan 2026 reached 13.08%, up 16.0%, while the annual FY2025 figure was 13.99%, 255.0% up from the prior year.
  • Net Margin for Q1 2026 was 12.75% at Medtronic, down from 15.41% in the prior quarter.
  • Across five years, Net Margin topped out at 19.1% in Q1 2022 and bottomed at 5.75% in Q4 2022.
  • The 5-year median for Net Margin is 13.24% (2024), against an average of 13.42%.
  • The largest annual shift saw Net Margin tumbled -1103bps in 2022 before it surged 566bps in 2023.
  • A 5-year view of Net Margin shows it stood at 5.75% in 2022, then soared by 98bps to 11.41% in 2023, then surged by 33bps to 15.21% in 2024, then increased by 1bps to 15.41% in 2025, then decreased by -17bps to 12.75% in 2026.
  • Per Business Quant, the three most recent readings for MDT's Net Margin are 12.75% (Q1 2026), 15.41% (Q4 2025), and 12.21% (Q3 2025).